XBIO · Xenetic Biosciences, Inc. · Executive Compensation
Market Cap
$5.60M
Shares
2.34M
Volume · Oct 5
9529
Avg daily vol (3M)
86.89K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jeffrey F. Eisenberg | Former Chief Executive Officer | $673,143 |
| Dr. Curtis Lockshin | Former Chief Scientific Officer | $554,083 |
| James Parslow | Interim Chief Executive Officer & Chief Financial Officer | $481,168 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jeffrey F. Eisenberg | Former Chief Executive Officer | $563,494 |
| Dr. Curtis Lockshin | Former Chief Scientific Officer | $435,816 |
| James Parslow | Interim Chief Executive Officer and Chief Financial Officer | $433,732 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jeffrey F. Eisenberg | Former Chief Executive Officer | $632,827 |
| James Parslow | Interim Chief Executive Officer and Chief Financial Officer | $473,990 |
| Dr. Curtis Lockshin | Former Chief Scientific Officer | $470,371 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jeffrey F. Eisenberg | Chief Executive Officer | $750,231 |
| James Parslow | Chief Financial Officer | $520,809 |
| Dr. Curtis Lockshin | Chief Scientific Officer | $508,320 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jeffrey F. Eisenberg | Chief Executive Officer | $446,357 |
| James Parslow | Chief Financial Officer | $359,412 |
| Dr. Curtis Lockshin | Chief Scientific Officer | $347,203 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jeffrey F. Eisenberg | Chief Executive Officer | $602,652 |
| James Parslow | Chief Financial Officer | $387,820 |
| Dr. Curtis Lockshin | Chief Scientific Officer | $383,793 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jeffrey F. Eisenberg | Chief Executive Officer | $318,333 |
| James Parslow | Chief Financial Officer | $287,595 |
| Dr. Curtis Lockshin | Chief Scientific Officer | $259,584 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| James F. Parslow | Interim Chief Executive Officer | Appointed | 2024-06-21 |
| Jeffrey F. Eisenberg | director | Resigned | 2024-05-22 |
| Dr. Curtis Lockshin | Chief Scientific Officer | Resigned | 2024-05-22 |
| James F. Parslow | Interim Chief Executive Officer | Appointed | 2024-05-22 |